INS and Obesity: The investigated transgenic mouse model shows a mild fatty liver, hepatic insulin resistance with compensatory increased ß-cell function, and massive obesity but no signs of inflammation and metabolically healthy adipose tissue (Knebel et al., 2012, 2019; Jelenik et al., 2017).